Transforming patient outcomes
The CNS therapeutic solutions market is witnessing huge growth, due to the aging global population and a surge in R&D. But it's not all plain sailing - in order to improve patient outcomes, researchers, stakeholders and regulatory bodies must address a range of complex challenges posed by these neurological and psychiatric disorders.
Delve into this eBook to gain invaluable insight across a myriad of topics, with articles including:
- Role of Digital Therapeutics in Central Nervous System Clinical Trials
- For Psychedelics, US FDA Is Open To Creative Thinking But Firm On Approval Standards
- Schizophrenia, Depression And Neuropathy: What’s Coming In 2024
- CGT Is In Its Infancy For CNS Disorders, But Technical Strides Being Made
- Pioneering Partnerships And Novel Trial Design Are Reshaping Repurposing In The CNS Space
